Generics Producers in Asia: Where Are the Big Opportunities

Table of Contents

• Double-Digit Growth
• Penetration Rising
• Value Of Asia' s Generic Drug Markets (US$bn)
• Population Of Select Asian Countries (mn)
• Year-On-Year Percentage Growth For Asia' s Generic Markets (2007 vs 2008)
• Per Capita Sepnding For Asia' s Generic Drug Markets During 2007 (US$)
• Generics In Industry Context
  • Table: Value Of Asia' s Generic Drug Markets (US$bn)
• Generics As Percent Of Total Pharmaceutical Market Value
  • Table: Pharmaceutical Business Environment Indicators

• Pharmaceutical Ratings - Methodology
• Ratings Overview
• Ratings System
• Indicators
• Weighting
• Australia
  • Table: Weighting Of Components
  • Table: Asia Pacific Business Environment Rankings
• China
• Hong Kong
• India
• Indonesia
• Japan
• Malaysia
• Pakistan
• Philippines
• Singapore
• South Korea
• Taiwan
• Thailand
• Vietnam

• Australia
  • Table: australia' s Generics And Patented Market Forecasts
• China
  • Table: China' s Generics Patented Market Forecasts
• Hong Kong
  • Table: India' s Generics And Patented Market Forecasts
• India
  • Table: HongKong' s Generics Patented Market Forecasts
• Indonesia
  • Table: Indonesia' s Generics And Patented Market Forecasts
• Japan
  • Table: Japan' s Generics And Patented Market Forecasts
• Malaysia
  • Table: Malaysia' s Generics And Patented Market Forecasts
• Pakistan
  • Table: Pakistan' s Generics And Patented Market Forecasts
• Philippines
  • Table: Philippines' Generics Patented Market Forecasts
• Singapore
  • Table: Singapore' s Generics Patented Market Forecasts
• South Korea
  • Table: South Korea' s Generics Patented Market Forecastss
• Taiwan
  • Table: Taiwan' s Generics And Patented Market Forecasts
• Thailand
  • Table: Thailand' s Generics Patented Market Forecasts
• Vietnam
  • Table: Vietnam' s Generics Patented Market Forecasts

• Sigma Pharmaceuticals
• Australian Pharmaceutical Industries
• Alphapharm

• North China Group Corporation (NCPC)
• China Biopharmaceuticals Holdings (CBH)
• Hubei Biocause Heilen Pharmaceutical
• Aida Pharmaceutical
• Shijiazhuang (CSPC)

• South Asia Pharmamedic Ltd
• C&Y Pharmaceutical Investment Holding
• Vida Laboratories

• Ranbaxy Laboratories
• Cipla
• Dr Reddy' s Laboratories
• Aurobindo Pharmaceutical
• Venus Remedies
• Granules India
• Nicholas Piramal
• Zydus Cadila

• PTKalbe Farma
• PTBio Farma
• Kimia Pharma
• PT SidoMuncul
• Combiphar PT
• Darya-Varia

• Sawai Pharmaceutica

• Pharmaniaga
• Asia Pharmaceutical Products
• Prime Pharmaceutical
• Bumimedic
• Hovid
• Chemical Company of Malaysia (CCM)
• Kotra Pharma
• YSPSoutheast Holding

• Hilton Pharma
• Efroze
• Ferozsons Laboratories

• Unilab
• Pascual
• Pacific Pharmaceuticals
• MediChem Pharmaceuticals

• SciGen Ltd.

• Hanmi Pharmaceutical Co.
• Kuhnil Pharmaceutical
• Choongwae

• Yung Shin Pharmaceutical (YSP)
• ScinoPharm Taiwan

• Siam Pharmaceutical
• Government Pharmaceutical Organisation (GPO)
• Biolab
• Thai Meiji Pharmaceutical Co.

• Vietnam Pharmaceutical Corporation (Vinapharm)
• Vietnam OPV Pharmaceutical Co
• Stada Vietnam
• Vidipha Central Pharmaceutical Joint Stock Company